GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (XCNQ:MBIO) » Definitions » Change In Other Working Capital

MindBio Therapeutics (XCNQ:MBIO) Change In Other Working Capital : C$-0.11 Mil (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics Change In Other Working Capital?

MindBio Therapeutics's Change In Other Working Capital for the quarter that ended in Sep. 2024 was C$0.00 Mil. It means MindBio Therapeutics's Other Working Capital stayed the same from Jun. 2024 to Sep. 2024 .

MindBio Therapeutics's Change In Other Working Capital for the fiscal year that ended in Jun. 2024 was C$-0.11 Mil. It means MindBio Therapeutics's Other Working Capital declined by C$0.11 Mil from Jun. 2023 to Jun. 2024 .

MindBio Therapeutics Change In Other Working Capital Historical Data

The historical data trend for MindBio Therapeutics's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics Change In Other Working Capital Chart

MindBio Therapeutics Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Change In Other Working Capital
- 0.04 0.10 -0.11

MindBio Therapeutics Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -0.11 -

MindBio Therapeutics Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MindBio Therapeutics Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of MindBio Therapeutics's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

MindBio Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (XCNQ:MBIO) » Definitions » Change In Other Working Capital
Comparable Companies
TSX:APLI TSXV:IOT XCNQ:MESC XCNQ:NOVA XCNQ:BIOV TSXV:RP XCNQ:GLOW TSXV:MRVL TSX:IPCI XCNQ:BRAX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
WF6:Germany
Address
91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000
Website
https://www.mindbiotherapeutics.com
MindBio Therapeutics Corp is engaged in the research, development, and testing of psychedelic substances as a potential treatment for the management of a broad range of mental health conditions. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough micro dosing studies. Geographically, the company's activities take place in Australia.